Report me for selling fake medicine? Why are you crying when your illness relapses?

He is the one who makes the final decision on everything, including the price of the medicine, and others can only give him suggestions at most.

"Okay! Then we won't bother you anymore."

Mo Xuefeng smiled and then led his men away.

Although nothing was agreed upon during today's negotiations, the overall atmosphere was very harmonious.

At least Chen Xuan did not refuse directly, which means that there is still room for negotiation on this matter, rather than a flat rejection.

It just takes time, and we have to continue to talk about it, but there is hope in the end. This makes him most satisfied, and he can report back when he goes back.

"This condition is quite sincere."

"The price of 5000 is quite reasonable."

After Mo Xuefeng left, Luo Shiyun directly expressed her thoughts.

For a moment, she thought the other party would quote an extremely low price for the medicine, but she didn't expect it to be 5000.

After all, as a medical insurance bureau, we also need to consider overall expenditures.

If the price of a drug is too high, the country will not be able to afford it, so naturally we have to consider the problem.

There are so many high-priced drugs, all of them life-saving. It's impossible for some to be allowed in while other life-saving drugs are not, right? That's definitely not possible.

Therefore, even if the drug is to be included in the medical insurance, the price must be reduced to a certain level.

As a country, we need to consider how to use limited resources to cover as large a group as possible.

Instead of using all resources to help only one group, this will only backfire.

"That's reasonable indeed."

Chen Xuan nodded, he also agreed with this.

After Mo Xuefeng mentioned the price, he could actually see the other party's sincerity.

This price has already taken Antai Pharmaceutical Group into consideration as much as possible, rather than simply asking Antai Pharmaceutical Group to make selfless contributions.

"If it can be included in medical insurance,"

"Then most patients in China can afford this medication cost."

"By then, most patients will be able to afford treatment, and our sales will be guaranteed, with both revenue and profits being considerable." Luo Shiyun mentioned this possibility.

In her opinion, this condition is still very beneficial to Antai Pharmaceutical Group.

It can guarantee that sales, revenue and profits will not be a problem, and it can also gain public reputation.

In the case that neither revenue nor profit will decrease, the public will have a favorable impression of Antai Pharmaceutical Group.

……

……

"We'll think about it for a few days before responding to each other."

Chen Xuan stated this decision directly.

He had no intention of refusing, he just needed to think about it for a few days.

For the same conditions, agreeing directly is completely different from agreeing a few days later, and the latter will attract a larger group of people.

At that time, these people will have to thank him for this favor and will take better care of Antai Pharmaceutical Group in the future. This is the best network.

Of course, the main reason why he agreed was to be able to enter the collection and be reimbursed by medical insurance.

Whether or not there is medical insurance reimbursement will have a significant impact on sales.

If medical insurance were to cover the cost, it would be very likely that the sales of lung cancer-specific drugs would increase tenfold.

On the one hand, the cost of medicine after reimbursement is affordable for most patients, so they will naturally choose this medicine.

On the other hand, after it is included in the medical insurance, doctors will also give priority to recommending this drug, directly opening up the largest market.

If it is not included in the medical insurance, if Antai Pharmaceutical Group wants to open sales channels in so many hospitals and get so many doctors to recommend the lung cancer drug, it is unknown how long it will take to complete the distribution.

But after it enters the medical insurance, the distribution will be completed by the Medical Insurance Bureau and can directly enter all hospitals. At least this drug will be available in public hospitals.

There is no doubt that this is the most convenient approach, which can save Antai Pharmaceutical Group time and resources in distributing products. This product originally required other costs, but now no further investment is required.